Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for ...

Cystatin C is an emerging biomarker that enhances kidney function assessment accuracy, particularly in hospitalized patients ...

HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on myCME.com. Clinical assessment of kidney function is central to the practice of ...

Living kidney donation necessitates rigorous pre‐donation evaluation to ensure donor safety and optimise postoperative outcomes. A critical component in this process is the accurate assessment of ...

Renalytix plc (LSE: RENX) (OTCQB: RNLXY), today announced an agreement with Tempus AI, Inc. (NASDAQ: TEM) to make kidneyintelX.dkd prognostic blood testing more widely available for eligible patients ...

The algorithm will be added to Roche's navify library of clinical decision-making algorithms and other digital health ...

Race-free kidney function equations may underestimate risks for Black adults according to a new analysis. A widely adopted race-free equation for estimating kidney function may underestimate the risk ...

There are a variety of differences among markers and clearance methods for GFR measurement compared with the classic method of inulin clearance. However, the bias appears relatively small, and ...

Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function.This tool will be launched as ...